VEGFA and colorectal carcinoma: To our knowledge, this retrospective analysis may represent the largest study conducted to date on the efficacy of PD-1 blocking antibodies versus anti-VEGF therapy specifically in Asian individuals with metastatic MSI-H/dMMR CRC.